Maciej Owecki

Prof. Dr. Maciej Owecki

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2021 in Journal of Endocrinological Investigation
Verified
Journal Article
Open access
PDF file
MMMałgorzata Mirr
Małgorzata Mirr
Damian SkrypnikDamian Skrypnik
Damian Skrypnik
PBP. Bogdański
P. Bogdański
MOMaciej Owecki
Maciej Owecki
Purpose: Obesity and insulin resistance are considered cardinal to the pathophysiology of metabolic syndrome. Several simple indexes of insulin resistance calculated from biochemical or anthropometric variables have been proposed. The study aimed to assess the diagnostic accuracy of indirect insulin resistance indicators in detecting metabolic syndrome in non-diabetic patients, including TG/HDLc, METS-IR, TyG, TyG-BMI, TyG-WC, TyG-WHtR, and new indicators TyG-NC (TyG-neck circumference) and TyG-NHtR (Tyg-neck circumference to height ratio). Methods: The diagnostic accuracy of eight insulin resistance indexes was assessed using the receiver operating characteristic curves (ROC curves) in 665 adult non-diabetic patients. Then, the analysis was performed after the division into groups with proper body mass index, overweight and obese. Results: All indexes achieved significant diagnostic accuracy, with the highest AUC (area under the curve) for TyG (0.888) and Tg/HDLc (0.874). The highest diagnostic performance in group with the proper body mass index was shown for TyG (0.909) and TyG-BMI (0.879). The highest accuracy in the group of overweight individuals was presented by TyG (0.884) and TG/HDLc (0.855). TG/HDLc and TyG showed the highest AUC (0.880 and 0.877, respectively) in the group with obesity. Both TyG-NC and TyG-NHtR reached significant areas under the curve, which makes them useful diagnostic tests in metabolic syndrome. Conclusions: Indirect indices of insulin resistance, including proposed TyG-NC and TyG-NHtR, show an essential diagnostic value in diagnosing metabolic syndrome. TyG and TG/HDLc seem to be the most useful in the Caucasian population.

1 January 2007 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
RPRalf Paus
Ralf Paus
JKJ. Klein
J. Klein
PPP. A. Permana
P. A. Permana
MOMaciej Owecki
Maciej Owecki
GCG. N. Chaldakov
G. N. Chaldakov
TRTerence J. Ryan
Terence J. Ryan

26 February 2015 in International Orthopaedics
Verified
Journal Article
Open access
PDF file
MRMagdalena Richter
Magdalena Richter
TTTomasz Trzeciak
Tomasz Trzeciak
MOMaciej Owecki
Maciej Owecki
APAndrzej Pucher
Andrzej Pucher
JKJacek Kaczmarczyk
Jacek Kaczmarczyk
Osteoarthritis (OA) is one of the most common causes of musculoskeletal disability in the world. Traditionally, it has been thought that obesity contributes to the development and progression of OA by increased mechanical load of the joint structures. Nevertheless, studies have shown that adipose tissue-derived cytokines (adipocytokines) are a possible link between obesity and OA. Furthermore, according to recent findings, not only articular cartilage may be the main target of these cytokines but also the synovial membrane, subchondral bone and infrapatellar fat pad may be encompassed in the process of degradation. This review presents the most recent reports on the contribution of adipocytokines to the knee joint cartilage degradation, osteophyte formation, infrapatellar fat pad alterations and synovitis.

1 October 2015 in Journal of Affective Disorders
Verified
Journal Article
Closed access
DŁDorota Łojko
Dorota Łojko
GBGrzegorz Buzuk
Grzegorz Buzuk
MOMaciej Owecki
Maciej Owecki
MRMarek Ruchała
Marek Ruchała
JRJanusz Kazimierz Rybakowski
Janusz Kazimierz Rybakowski

8 September 2010 in Experimental and Clinical Endocrinology & Diabetes
Verified
Journal Article
Closed access
PDF file
MOMaciej Owecki
Maciej Owecki
AMA. Miczke
A. Miczke
ENE. Nikisch
E. Nikisch
DPD. Pupek-Musialik
D. Pupek-Musialik
JSJ. Sowiński
J. Sowiński
Although obesity may be linked to resistin, the role of resistin in humans is still controversial. Conflicting results of the associations between resistin and BMI and measures of insulin resistance were reported. In view of the yet unexplained role of resistin in human obesity, the aim of this study was to examine correlations between serum resistin concentrations and the degree of human obesity and insulin sensitivity. For this purpose, we investigated 2 homogenous groups of obese and non obese humans, in whom the presence of obesity was the solely differentiating factor. The WHO definition of obesity was used. Study group consisted of 136 obese subjects (75 women and 61 men) and 48 non-obese controls (31 women, 17 men) aged 48.0±10.1, and 48.8±13.4 yrs, respectively. Results: Obese subjects showed higher resistin concentrations than non obese controls (24.89±9.73 ng/mL, median 26.61 vs. 15.34±4.68 ng/mL, median 14.76, P<0.0001). Resistin concentrations correlated with BMI in the whole cohort (r=0.4296, P<0.0001), but not in obese and non-obese subjects separately (r=0.1418, P=0.0997; r=0.2712, P=0.0623, respectively). Moreover, serum resistin was not influenced by insulin resistance in either group examined. Conclusion: Although concentrations of resistin differ between obese and non-obese humans, no relationship between resistin concentration and insulin resistance has been found. Correlations between resistin and BMI are present only in a mixed population but disappear in non obese and obese subjects when analyzed separately.

7 May 2010 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
MOMaciej Owecki
Maciej Owecki
ENE. Nikisch
E. Nikisch
AMA. Miczke
A. Miczke
DPD. Pupek-Musialik
D. Pupek-Musialik
JSJ. Sowiński
J. Sowiński
Leptin binds to the soluble form of its receptor (sOB-R). Leptin and sOB-R balance (free leptin index, FLI) reflect leptin activity. Leptin correlates with obesity and insulin resistance, but it remains uncertain whether sOB-R and FLI also do the same. Therefore, the aim of this study was to measure serum leptin, sOB-R, and FLI, and evaluate their associations with BMI and insulin resistance. We studied 145 obese and 49 nonobese humans. Obesity was defined according to WHO (BMI >30 kg/m2). Results are given as: median and interquartile range, obese vs. nonobese, respectively. Leptin (ng/ml): 30.83, 37.27 vs. 8.31, 10.04; sOB-R (ng/ml): 17.62, 17.05 vs. 27.25, 11.30; FLI: 231.2, 310.0 vs. 30.85, 27.77; HOMA: 5.99, 6.64 vs. 3.92, 4.52; p<0.001 for all. Serum leptin, sOB-R, and FLI did not correlate with insulin resistance separately in obese and nonobese humans. Leptin and FLI, but not sOB-R, were associated with insulin resistance in obese and nonobese subjects examined together. Leptin, sOB-R and FLI differed between obese and nonobese humans, and, except sOB-R, correlated with BMI. In piecewise linear regression, BMI threshold where leptin increased was 24.6 (r=0.5969, p=0.00016 and <0.00001). Leptin and its free index, but not sOB-R, correlate with BMI only in a mixed obese and nonobese human cohort, and not in isolated obese or nonobese groups. Moreover, BMI threshold where leptin starts to increase is 24.6 kg/m2, which is lower than the cutoff for overweight. Under the conditions, metabolic abnormalities may occur in parallel to much lower BMI levels as expected so far.